SEEMA HAQUE: Open Payments
NPI 1396784914 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 10 payments from 6 companies in 2025. Trend: 2023 $628 · 2024 $168 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $198 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $17 |
| Soleno Therapeutics, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: LYBALVI, ARISTADA, INVEGA SUSTENNA, CAPLYTA, Quviviq, VYKAT XR, REXULTI.
Industry payments across TX — which companies pay providers there.
